14:46 EDT Apellis Pharmaceuticals trading halted, volatility trading pause
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on APLS:
- Stifel expects pressure on Apellis ‘to be short-lived’
- JPMorgan says Apellis retinal vasculitis events rare, stays Overweight
- Apellis sinks after Raymond James highlights vasculitis notification
- Apellis price target raised to $115 from $105 at Baird
- Apellis Announces Seven Abstracts Accepted for Oral Presentation at the American Society of Retina Specialists (ASRS) Annual Scientific Meeting